arrow
V

Virginie Siguret

universite paris cite
H指数:32
被引数:4,221

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of Monocyte Subsets in a Prospective Cohort of Patients with Acute Stroke Suspicion: Results of BOOST Study

急性卒中疑似患者前瞻性队列中单核细胞亚群的表征:BOOST研究的结果

2026-02-010
OA
Laboratory Monitoring of UFH in Different Settings (DEXHEP Study): Association between Anti-Xa Levels, Platelet Factor 4 (PF4) Plasma Levels and Dextran Sulfate

不同临床环境下UFH的实验室监测(DEXHEP研究):抗Xa水平、血小板因子4(PF4)血浆水平与右旋糖酐硫酸盐之间的关系

2025-12-010
OA
Fibrinography and thrombography (Thrombodynamics-4D) in atrial fibrillation ADAGE patients aged 80 years and older receiving DOAC therapy

纤维蛋白图和血栓图(Thrombodynamics-4D)在年龄80岁及以上、接受DOAC治疗的房颤ADAGE患者中的应用

2025-07-150
OAAI
Anticoagulant management in emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP)*

急诊抗凝管理:2024年法国急诊医学学会(SFMU)、法国麻醉与重症监护医学学会(SFAR)、法国血栓与止血学会(SFTH)及法国围手术期止血工作组(GIHP)指南*

2025-06-260
PRE
The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia
2024-08-012
OAAI
Bothrops atrox and Bothrops lanceolatus Venoms In Vitro Investigation: Composition, Procoagulant Effects, Co-Factor Dependency, and Correction Using Antivenoms

Atrops和botrops lanceolatus毒液的体外研究: 成分,促凝血作用,辅因子依赖性和使用抗蛇毒血清的校正

2023-10-164
OAAI
Factors Influencing anti-Xa assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin
2023-06-159
PRE
C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study
2023-03-015
OAAI